Alpha Cognition (XCNQ:ACOG) Cash-to-Debt : 1.15 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Alpha Cognition Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Alpha Cognition's cash to debt ratio for the quarter that ended in Dec. 2023 was 1.15.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Alpha Cognition could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Alpha Cognition's Cash-to-Debt or its related term are showing as below:

XCNQ:ACOG' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.15 Med: 1.78 Max: 10.51
Current: 1.15

During the past 4 years, Alpha Cognition's highest Cash to Debt Ratio was 10.51. The lowest was 1.15. And the median was 1.78.

XCNQ:ACOG's Cash-to-Debt is ranked worse than
74.56% of 1541 companies
in the Biotechnology industry
Industry Median: 6.49 vs XCNQ:ACOG: 1.15

Alpha Cognition Cash-to-Debt Historical Data

The historical data trend for Alpha Cognition's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Alpha Cognition Cash-to-Debt Chart

Alpha Cognition Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

1.84

10.51

1.72

1.15

Alpha Cognition Quarterly Data
	Jan20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial									1.72	3.32	1.07	0.61	1.15

Competitive Comparison of Alpha Cognition's Cash-to-Debt

For the Biotechnology subindustry, Alpha Cognition's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alpha Cognition's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Cognition's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Alpha Cognition's Cash-to-Debt falls into.

Alpha Cognition Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Alpha Cognition's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1.884	/	(1.637	+	0)
	=	1.15

Alpha Cognition's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1.884	/	(1.637	+	0)
	=	1.15

Alpha Cognition (XCNQ:ACOG) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Alpha Cognition Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Alpha Cognition's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpha Cognition (XCNQ:ACOG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Cognition Inc (XCNQ:ACOG) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

ACOGF:USA

Address

301 - 1228 Hamilton Street, Vancouver, BC, CAN, V6B 6L2

Website

https://www.alphacognition.com

Alpha Cognition Inc is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, and Cognitive Impairment with Mild Traumatic Brain Injury (mTBI) for which there are limited or no treatment options. The Company is focused on the development of ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease and completed an NDA filing to the FDA in September 2023. The company anticipates an FDA approval in mid-2024. The Company's ALPHA-1062 development program is primarily focused on clinical and regulatory development, Chemistry, Manufacturing and Control (CMC) development, and commercial readiness.

Alpha Cognition (XCNQ:ACOG) Headlines

No Headlines